Pneumococcal meningitis still with us in the era of conjugate vaccines

Acta Paediatrica, International Journal of Paediatrics

Volumn 99, Issue 11, 2010, Pages 1600-1601

  Peltola, Ville ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Meningitis; Pneumococcal conjugate vaccine; Serotype replacement; Streptococcus pneumoniae

Indexed keywords

PNEUMOCOCCUS VACCINE; TEN VALENT PROTEIN POLYSACCHARIDE CONJUGATE VACCINE; THIRTEEN VALENT PROTEIN POLYSACCHARIDE CONJUGATE VACCINE; UNCLASSIFIED DRUG;

BACTERIAL COLONIZATION; DRUG EFFICACY; HUMAN; INCIDENCE; NASOPHARYNX; NONHUMAN; NOTE; OTITIS MEDIA; PNEUMOCOCCAL MENINGITIS; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

CHILD; FRANCE; HUMANS; IMMUNIZATION PROGRAMS; INFANT; MENINGITIS, PNEUMOCOCCAL; PNEUMOCOCCAL VACCINES; VACCINES, CONJUGATE; WORLD HEALTH;

EID: 78649734531     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2010.01965.x     Document Type: Note

References (10)

1. Alexandre C, Dubos F, Courouble C, Pruvost I, Varon E, the Hospital Network for Evaluating the Management of Common Childhood Diseases, Martinot A. Rebound in the incidence of pneumococcal meningitis in northern France: Effect of serotype replacement. Acta Paediatr 2010; 99: 1686-90.
2. Whitney CG, Farley MM, Hadler J, Harrison LH, Bennett NM, Lynfield R, et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 2003; 348: 1737-46.
3. Jefferson T, Ferroni E, Curtale F, Giorgi Rossi P, Borgia P. Streptococcus pneumoniae in western Europe: Serotype distribution and incidence in children less than 2 years old. Lancet Infect Dis 2006; 6: 405-10.
4. O'Brien KL, Millar EV, Zell ER, Bronsdon M, Weatherholtz R, Reid R, et al. Effect of pneumococcal conjugate vaccine on nasopharyngeal colonization among immunized and unimmunized children in a community-randomized trial. J Infect Dis 2007; 196: 1211-20.
5. Pilishvili T, Lexau C, Farley MM, Hadler J, Harrison LH, Bennett NM, et al. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis 2010; 201: 32-41.
6. Hsu HE, Shutt KA, Moore MR, Beall BW, Bennett NM, Craig AS, et al. Effect of pneumococcal conjugate vaccine on pneumococcal meningitis. N Engl J Med 2009; 360: 244-56.
7. Singleton RJ, Hennessy TW, Bulkow LR, Hammitt LL, Zulz T, Hurlburt DA, et al. Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA 2007; 297: 1784-92.
8. Techasaensiri C, Messina AF, Katz K, Ahmad N, Huang R, McCracken GH Jr. Epidemiology and evolution of invasive pneumococcal disease caused by multidrug resistant serotypes of 19A in the 8 years after implementation of pneumococcal conjugate vaccine immunization in Dallas, Texas. Pediatr Infect Dis J 2010; 29: 294-300.
9. Harboe ZB, Benfield TL, Valentiner-Branth P, Hjuler T, Lambertsen L, Kaltoft M, et al. Temporal trends in invasive pneumococcal disease and pneumococcal serotypes over 7 decades. Clin Infect Dis 2010; 50: 329-37.
10. Greenberg D, Givon-Lavi N, Sharf AZ, Vardy D, Dagan R. The association between antibiotic use in the community and nasopharyngeal carriage of antibiotic resistant Streptococcus pneumoniae in Bedouin children. Pediatr Infect Dis J 2008; 27: 776-82.